14151 Background: Pancreatic cancer is virtually always lethal, and the only FDA-approved
therapies-gemcitabine and erlotinib-produce objective responses in less than 10% of …

4599 Background: Pancreatic cancer is virtually always lethal, and the only FDA-approved
therapies–gemcitabine and erlotinib–produce objective responses in less than 10% of …

Purpose: Pancreatic cancer is almost always lethal, and the only US Food and Drug
Administration–approved therapies for it, gemcitabine and erlotinib, produce objective …

15619 Background: The anti-metabolite gemcitabine is the standard chemotherapy for
advanced pancreatic cancer. Yet, it produces an objective response in less than 10% of …

A number of preclinical studies have demonstrated anticancer effects for curcumin in various
types of tumors, including pancreatic cancer. Curcumin has anticancer effects both alone …

Curcumin has a potent antiproliferative activity and can also potentiate the antitumor effect of
gemcitabine. This study was undertaken to evaluate the activity and feasibility of …

Pancreatic cancer (PC) is one of the deadliest cancers worldwide. Surgical resection
remains the only curative therapeutic treatment for this disease, although only the minority of …

Purpose Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer
drug and shows synergic effects with cytotoxic agents. We evaluated the safety and …

Pancreatic cancer is one of the most devastating types of cancer. The American Cancer
Society has estimated that 48,960 individuals will be diagnosed with pancreatic cancer in …

Pancreatic cancer is among the leading cause of deaths due to cancer with extremely poor
prognosis. Gemcitabine is being used in the treatment of patient with pancreatic ductal …